Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA
{{output}}
Though there has been substantial progress in the development of anti-human epidermal growth factor receptor 2 (HER2) therapies to treat HER2-positive metastatic breast cancer (MBC) within the past two decades, most patients still experience disease progressio... ...
